Saturday, April 13, 2024
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

BioCubaFarma

Moscow, Dec 7 (Prensa Latina) The leading products of the Cuban biotechnological and pharmaceutical sector are on display at the Russia Health Care Week 2023, Idania Caballero, director of the BioCubaFarma office in this capital, confirmed on Thursday.
Minsk, Feb 26 (Prensa Latina) A Cuban medical and biotechnology delegation that arrived in this capital on Sunday will participate in a business forum of producers and exporters, Ambassador Santiago Perez announced.
Havana, Jan 18 (Prensa Latina) Eduardo Martinez, the Biotechnological and Pharmaceutical Industries of Cuba (BioCubaFarma) President, announced on Wednesday the resumption of Fluticasone and Salbutamol production.
Havana, Dec 27 (Prensa Latina) Cuban President Miguel-Díaz Canel on Tuesday attended the official ceremony for the 10th anniversary of the Biotechnological and Pharmaceutical Industries of Cuba (Biocubafarma) Business Group.
Havana, Nov 17 (Prensa Latina) The Cuban Business Group BioCubaFarma and the AZCUBA Sugar Group have strengthened bilateral cooperation in the framework of the 38th Havana International Fair (FIHAV 2022).
Havana, Jul 5 (Prensa Latina) The government of Bayelsa, an important Nigerian state, and the BioCubaFarma Group signed here today a Memorandum of Understanding (MoU) aimed at establishing a long-term biopharmaceutical alliance for the co-production of vaccines and other drugs.
Havana, Sep 2 (Prensa Latina) BioCubaFarma Business Group on Wednesday denied CNN´s information about alleged refusal from the World Health Organization (WHO) to certify Cuba's Covid-19 vaccines. The CNN aired on Wednesday that WHO refused authorization for the emergency use of Cuban vaccine candidate (Abdala), so it cannot be purchased through the Revolving Fund of the Pan American Health Organization (PAHO).
Havana, Jun 22 (Prensa Latina) With more than 100 innovation projects, the Cuban Group of Biotechnological and Pharmaceutical Industries (BioCubaFarma) currently continues with the development of new medications, despite the United States blockade against the Caribbean nation.